We found that sulfotransferase activity in the glycan pathway was associated with poor prognosis; however, in our previous pan-cancer analysis, CHST14 was shown to be highly expressed in high-energy-metabolism TCGA gastric cancers with high EMT [9]. Here, CHST14 is linked to cancer.